Strug­gling MannKind sees shares rock­et up on $105M-plus al­liance with Unit­ed on in­haled tre­pros­tinil

The long suf­fer­ing MannKind Corp $MNKD is pock­et­ing $55 mil­lion as it launch­es a new col­lab­o­ra­tion with Unit­ed Ther­a­peu­tics to use its tech to de­vel­op …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.